Scholars Central

Conference abstractPublished 2017

The molecular classification of women’s breast cancer, therapeutic interest, experience of Sidi Bel Abbes, Algeria

Authors: Nawel Agher

University Djilali Liabés, Sidi Bel Abbes, Algeria Ben Hamida Laboratory, Algeria

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The heterogeneity of molecular abnormalities presented by breast cancers and the in-depth knowledge of these potential targets is a promising source of targeted therapy. The development of these therapeutic targets makes it possible to envisage the development of customized therapeutic combinations adapted to the intrinsic cancer characteristics. The aim of our work is to carry out a descriptive, histopathological study and to apply the molecular classification. We selected 237 women with breast cancer at the Pathology Department of the Sidi Bel Abbés Hospital Center, Algeria. We could identify for each cancer, the molecular class according to its immunohistochemical profile by the study of hormonal receptors oestrogen and progesterone, the status of the oncogene HER2/neu and completed by the in-situ hybridization by fluorescence (FISH) technique for the cases with HER2 score 2. According to the molecular classification of breast cancers, our sample presents: HER2 positive tumors, whose prognosis was significantly modified by targeted therapies: 35%, Two major types of tumors expressing hormonal (HR) receptors: weakly proliferating and of good prognosis luminal A, and proliferating with a lower luminal B prognosis with: Luminal A- 16% and Luminal B- 29%, Triple-negative tumors (RE-, RP- and HER2-): 20%, completed by studying the markers: CK5/6, P63. The "intrinsic" genomic expression signature that distinguishes several major categories of breast cancers has clearly shown its prognostic and even therapeutic interest in clinical practice. This necessitates the importance of developing the appropriate care for these patients and the installation of the techniques necessary for the choice of therapeutics.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Womens Health, Issues and Care
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “Nawel Agher”